Secured Retirement Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Buy
10,052
+8,277
+466% +$1.78M 1.3% 13
2026
Q1
$386K Buy
1,775
+90
+5% +$20K 0.22% 115
2025
Q4
$385K Buy
1,685
+62
+4% +$14.1K 0.22% 103
2025
Q3
$376K Buy
1,623
+488
+43% +$99.4K 0.21% 105
2025
Q2
$211K Sell
1,135
-39
-3% -$7.25K 0.13% 112
2025
Q1
$246K Sell
1,174
-400
-25% -$77.8K 0.16% 108
2024
Q4
$280K Buy
1,574
+100
+7% +$18.4K 0.16% 121
2024
Q3
$291K Buy
1,474
+44
+3% +$8.21K 0.21% 93
2024
Q2
$245K Buy
1,430
+153
+12% +$25.3K 0.19% 103
2024
Q1
$233K Buy
+1,277
New +$220K 0.2% 100

Other funds holding ABBV

Secured Retirement Advisors's ABBV Position: Q2 2026 in Review

Secured Retirement Advisors increased its AbbVie (ABBV) stake by 466% in Q2 2026, buying an estimated $1.78M and bringing the position to 10,052 shares worth $2.53M. The position accounts for 1.3% of the portfolio, ranked #13.

Secured Retirement Advisors first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Secured Retirement Advisors held 10,052 shares of AbbVie worth $2.53M as of Q2 2026.
  • Secured Retirement Advisors bought 8,277 AbbVie shares in Q2 2026, an estimated $1.78M.
  • AbbVie made up 1.3% of Secured Retirement Advisors's portfolio in Q2 2026, its #13 holding.
  • Secured Retirement Advisors first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Secured Retirement Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.